Welcome to LookChem.com Sign In|Join Free
  • or
(1-benzyl-1H-pyrrol-2-yl)methanol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1007389-00-5

Post Buying Request

1007389-00-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1007389-00-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1007389-00-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,3,8 and 9 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1007389-00:
(9*1)+(8*0)+(7*0)+(6*7)+(5*3)+(4*8)+(3*9)+(2*0)+(1*0)=125
125 % 10 = 5
So 1007389-00-5 is a valid CAS Registry Number.

1007389-00-5Relevant academic research and scientific papers

Controlled Reduction of Carboxamides to Alcohols or Amines by Zinc Hydrides

Ong, Derek Yiren,Yen, Zhihao,Yoshii, Asami,Revillo Imbernon, Julia,Takita, Ryo,Chiba, Shunsuke

supporting information, p. 4992 - 4997 (2019/03/13)

New protocols for controlled reduction of carboxamides to either alcohols or amines were established using a combination of sodium hydride (NaH) and zinc halides (ZnX2). Use of a different halide on ZnX2 dictates the selectivity, wherein the NaH-ZnI2 system delivers alcohols and NaH-ZnCl2 gives amines. Extensive mechanistic studies by experimental and theoretical approaches imply that polymeric zinc hydride (ZnH2)∞ is responsible for alcohol formation, whereas dimeric zinc chloride hydride (H?Zn?Cl)2 is the key species for the production of amines.

FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE

-

Page/Page column 73, (2008/06/13)

This invention provides novel inhibitors of the enzyme D-amino acid oxidase as well as pharmaceutical compositions including the compounds of the invention. The invention also provides methods for the treatment and prevention of neurological disorders, such as neuropsychiatric and neurodegenerative diseases, as well as pain, ataxia and convulsion. The compounds of the invention have the general structure: wherein A is NH or S. Q is a member selected from CR1 and N. X and Y are members independently selected from O, S, CR2, N and NH. R1, R2 and R4 are members independently selected from H and F, provided that at least one member selected from R1, R2 and R4 is F. R6 is a member selected from O?X+ and OH, wherein X+ is a positive ion, which is a member selected from inorganic positive ions and organic positive ions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1007389-00-5